Justice Department Announces Largest Health Care Fraud Settlement in Its History Pfizer to Pay $2.3 Billion for Fraudulent Marketing......
Companies in the Buzz
Recommended Sources
Recommended Publications
About Pharma Industry
BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.
Web Buzz:
-
Pfizer agrees record fraud fine
BBC - 83 days 1 hour 32 minutes ago
US drugmaker Pfizer has agreed to pay $2.3bn (£1.4bn) in the largest healthcare fraud settlement in the history of the Department of Justice. A...
-
Pfizer pays $2.5 billion for deceptive marketing practices
Medical Marketing and Media -
83 days 3 hours 18 minutes ago
The world's largest pharmaceutical company, Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. have agreed to pay $2.3 billion, the...
-
Pfizer agrees to plead guilty in painkiller case
Financial Times - 82 days 23 hours 8 minutes ago
Pfizer, the world’s largest pharmaceutical group, on Wednesday agreed to plead guilty to illegally promoting its painkiller Bextra, as part of a...
-
Pfizer to Pay ���£1.4 Billion in Fines
Reuters UK -
82 days 22 hours 24 minutes ago
By Ransdell Pierson and Jeremy Pelofsky NEW YORK/WASHINGTON (Reuters UK) - Pfizer (PFE) agreed on Wednesday to plead guilty to a U.S. criminal...
-
Feds Make a Point with Huge Pfizer Fine
BusinessWeek -
82 days 20 hours 37 minutes ago
By Catherine Arnst Pfizer (PFE) will pay a record $2.3 billion fine and plead guilty to one felony count to settle federal criminal and civil...
-
Drugmaker Pfizer to Pay Record Penalty In Improper-Marketing Case
Washington Post - 82 days 14 hours 55 minutes ago
The Obama administration intensified its public campaign against health-care fraud Wednesday, putting drugmakers on notice that they will be forced...
- Novartis Looks at Combination Pills to Fix Hypertension Franchise
- Study Showing Drug Ads Are Linked to Higher Prices Has Flaws
- Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them
- Pfizer Got $160M in Tax Money to Build in Connecticut
- Sanofi's Viehbacher Backs Health Reform; May Change Company's Name
- Viagra Now Available Intravenously
- Genzyme Kidney Drug Failed, Too...What Could Possibly Happen Next?
- Peter Pitts' CMPI Targeted Over Anti-Healthcare Reform Video Game
- Why Allergan and Medicis Should Embrace the "Botox Tax" in Senate Health Bill
- Why J&J's Stelara Launch Should Target Dermatologists First
- NHS Loses Fight Over Publication of Antipsychotic Meds Brochures for Kids
- Genzyme's Termeer Got $50M in Compensation Over Last 3 Years; Wife Got Trips to Asia on Corporate Jet
- Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash
- Why Pfizer Wants Your Car-Sick Dog to Travel on Thanksgiving
- FDA Delays Genzyme's Lumizyme, Manufacturing Problems Blamed
- Will FDA Approve MannKind's Insulin Inhaler?
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted
- Hepatitis C Drugs Kill the Virus...and Your Sex Drive
- Microchip Implant to Link Your Health Records, Credit History, Social Security
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
- NYT's MannKind Story Needlessly Quoted a Competitor Bashing Afresa
- Novartis CEO Sends Emails to 140 Animal Rights Activists:
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low
- How NOT to Write a Biotech Press Release: Just Ask Epeius
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
- The 10 Weirdest Drug Stories of the Month
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity"
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check
Industry Transcripts by Seeking Alpha
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
BNET User Analysis